ROACH’S INTRODUCTORY TO CLINICAL
PHARMACOLOGY 11TH EDITION EXAM PAPER
2026 FULL QUESTIONS AND VERIFIED
ANSWERS
◉ Pharmaceutic Phase. Answer: Dissolution of the drug
◉ Pharmacokinetic Phase. Answer: All activities within the body
after a drug is administered. from absorption to excretion
◉ Absorbtion. Answer: process by which a drug is made available to
the body after dissolution.
◉ Active transport. Answer: cellular energy used in movement of the
drug
◉ Passive transport. Answer: No cellular energy used. high to low
concentration
◉ pinocytosis. Answer: Cell drinking.
◉ First pass effect. Answer: Amount metabolized by the liver
, ◉ clinical testing phase 1. Answer: 20 - 100 healthy volunteers
◉ clinical testing phase 2. Answer: test on target subjects
◉ clinical testing phase 3. Answer: Test on large number of subjects
with disease
◉ Pre-FDA phase. Answer: In-vitro testing
◉ Orphaned drugs. Answer: drugs not deemed cost effective to
produce for > 200K people
◉ Accelerated Phase. Answer: FDA pass into production after
positive phase 1, 2 trials.
◉ Pharmacodynamics. Answer: study of the drug mechanisms that
produce biochemical changes in the body. (primary effects are
desired, secondary effects are all other effects)
◉ Half-life. Answer: Time required to eliminate 50% of a drug from
the body
PHARMACOLOGY 11TH EDITION EXAM PAPER
2026 FULL QUESTIONS AND VERIFIED
ANSWERS
◉ Pharmaceutic Phase. Answer: Dissolution of the drug
◉ Pharmacokinetic Phase. Answer: All activities within the body
after a drug is administered. from absorption to excretion
◉ Absorbtion. Answer: process by which a drug is made available to
the body after dissolution.
◉ Active transport. Answer: cellular energy used in movement of the
drug
◉ Passive transport. Answer: No cellular energy used. high to low
concentration
◉ pinocytosis. Answer: Cell drinking.
◉ First pass effect. Answer: Amount metabolized by the liver
, ◉ clinical testing phase 1. Answer: 20 - 100 healthy volunteers
◉ clinical testing phase 2. Answer: test on target subjects
◉ clinical testing phase 3. Answer: Test on large number of subjects
with disease
◉ Pre-FDA phase. Answer: In-vitro testing
◉ Orphaned drugs. Answer: drugs not deemed cost effective to
produce for > 200K people
◉ Accelerated Phase. Answer: FDA pass into production after
positive phase 1, 2 trials.
◉ Pharmacodynamics. Answer: study of the drug mechanisms that
produce biochemical changes in the body. (primary effects are
desired, secondary effects are all other effects)
◉ Half-life. Answer: Time required to eliminate 50% of a drug from
the body
